Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of …
Y Hanai, Y Takahashi, T Niwa, T Mayumi… - Journal of …, 2022 - academic.oup.com
Background Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …
in patients with infections caused by MRSA. To promote the better management of patients …
Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of …
Y Hanai, Y Takahashi, T Niwa, T Mayumi… - The Journal of …, 2022 - europepmc.org
Background Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …
in patients with infections caused by MRSA. To promote the better management of patients …
Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of …
Y Hanai, Y Takahashi, T Niwa, T Mayumi… - Journal of Antimicrobial …, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Owing to its low risk of adverse effects, teicoplanin has been extensively used in patients …
Owing to its low risk of adverse effects, teicoplanin has been extensively used in patients …
[HTML][HTML] Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese …
Y Hanai, Y Takahashi, T Niwa, T Mayumi… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …
in patients with infections caused by MRSA. To promote the better management of patients …
[PDF][PDF] Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese …
Y Hanai, Y Takahashi, T Niwa, T Mayumi… - Journal of …, 2022 - academic.oup.com
Background Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …
in patients with infections caused by MRSA. To promote the better management of patients …
Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese society of chemotherapy and the Japanese society of …
Y Hanai, Y Takahashi, T Niwa, T Mayumi, Y Hamada… - 2022 - cabidigitallibrary.org
Background: Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …
in patients with infections caused by MRSA. To promote the better management of patients …
Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of …
Y Hanai, Y Takahashi, T Niwa… - The Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …
in patients with infections caused by MRSA. To promote the better management of patients …
Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: A consensus review by the Japanese Society of Chemotherapy and the Japanese Society of …
Y Hanai, Y Takahashi, T Niwa… - Journal of …, 2022 - keio.elsevierpure.com
Background: Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …
in patients with infections caused by MRSA. To promote the better management of patients …
Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: A consensus review by the Japanese Society of Chemotherapy and the Japanese Society of …
Y Hanai, Y Takahashi, T Niwa… - Journal of …, 2022 - keio.elsevierpure.com
Background: Owing to its low risk of adverse effects, teicoplanin has been extensively used
in patients with infections caused by MRSA. To promote the better management of patients …
in patients with infections caused by MRSA. To promote the better management of patients …